Skip to content
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Aureus Santa Marta
Education
MyMedi.ca
Contact
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Aureus Santa Marta
Education
MyMedi.ca
Contact
Instagram
Twitter
Linkedin
Linkedin
Twitter
Instagram
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Aureus Santa Marta
Education
MyMedi.ca
Contact
×
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Aureus Santa Marta
Education
MyMedi.ca
Contact
Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company
15 February 2024
Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™
13 February 2024
Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company
5 February 2024
Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil
30 January 2024
Avicanna Reports Q3 2023 Results
14 November 2023
Avicanna Announces Appointment of Paul Fornazzari to Board of Directors
14 November 2023
« Prev
1
2
3
4
5
6
7
Next »